
Chicken Crimpy biscuits finally go gluten-free: 'This is huge'
Arnott's has just confirmed the release of their most requested gluten-free product ever - Shapes in Chicken Crimpy flavour.
The cult-favourite, cheesy, melt-in-your-mouth biscuit has been given the gluten-free treatment, and fans are already calling it a game-changer.
Crafted using Arnott's Aussie-made gluten free baking blend, the new snacks deliver the same signature flavour, satisfying crunch and their moreish taste - minus any gluten.
After being flooded with messages and requests from Coeliacs and gluten-avoiding Aussies alike, Arnott's has officially delivered the goods.
'Please do gluten free chicken crimpies, I'm beggin',' wrote one die-hard fan.
'Hope you will be making other flavours like pizza and chicken in gluten free' said one mum. 'My little girls love them and can't have them at the moment.'
Chicken Crimpy has consistently ranked among Arnott's top five Shapes flavours, and the call to create a gluten free version was deafening.
The announcement of a new gluten-free flavour sparked a frenzy online, with social media users flooding comments sections with excitement and anticipation
Now, following the huge success of Gluten Free Shapes Barbecue and Gluten Free Jatz, the Aussie biscuit giant has expanded their savoury range again, with fans already scrambling to get their hands on a box.
The announcement of a new gluten-free flavour sparked a frenzy online, with social media users flooding comments sections with excitement and anticipation.
'Mum how did we get so rich…? 'Well son, your dad was the CEO of Shapes and he release GLUTEN FREE Chicken Crimpys… the company made billions,' one fan joked.
Good news for those with serious dietary needs, the new launch is endorsed by Coeliac Australia and New Zealand.
This makes them safe for those with diagnosed Coeliac disease and anyone avoiding gluten altogether.
They join Arnott's already stacked gluten free lineup, which includes sweet and savoury favourites like Gluten Free Tim Tams, Scotch Fingers, Mint Slice and TeeVee Snacks, which have all been reformulated without compromising on taste or texture.
From later this month, shoppers will be able to pick up the new Arnott's Gluten Free Shapes Chicken Crimpy at Coles, Woolworths and independent retailers across the country, for $5.50.
Whether you are gluten intolerant, avoiding it for health reasons, or just like feeding everyone at the party without excluding anyone, these new savoury crackers be your new pantry MVP.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medical News Today
3 hours ago
- Medical News Today
New weekly injection may eliminate need for daily pills in Parkinson's
Parkinson's symptoms develop slowly, most commonly after the age of 50, and include tremor, slowness in movement, limb stiffness, problems with gait and balance, sleep disorders, and mental health with Parkinson's disease have to take several tablets each day to help alleviate their a team of scientists in Australia has developed a weekly injectable treatment for Parkinson's further research proves the injection's safety and efficacy, the long-acting implant could be life changing for people living with Parkinson' disease is the second most common neurodegenerative condition after Alzheimer's Disease. It affects almost 1.1 million people in the United States and more than 10 million worldwide. Of these, 96% are diagnosed after the age of condition occurs when nerve cells in an area of the brain called the substantia nigra stop producing enough of the neurotransmitter dopamine. This leads to a range of symptoms, including:Tremor, or shaking, in hands, arms, legs, jaw, or headMuscle stiffnessSlowness of movementImpaired balance and two main treatments for Parkinson's disease are levodopa (L-dopa), which nerve cells use to make dopamine, and carbidopa, which increases the efficacy of levodopa and helps minimize its side effects. However, people need to take the medications several times a day, which many find difficult to scientists in Australia have developed a long-acting injectable treatment combining the two medications. Because the implant releases the drugs slowly over seven days, people with the condition would no longer have to take multiple tablets every study findings suggest that the injection could be 'a promising system for the delivery of levodopa and carbidopa for Parkinson's patients'.Sneha Mantri, MD MS, Chief Medical Officer for the Parkinson's Foundation, who was not involved in the study, agreed:'If this medication is safe and effective in humans, it could be an alternative for people with [Parkinson's] compared to multiple daily pills.'The findings are published in the journal Drug Delivery and Translational alternative to multiple daily pillsThe injection contains a combination of levodopa (L-dopa) and carbidopa, two drugs used together to treat Parkinson's disease. L-dopa can cross the blood-brain barrier into the central nervous system, where it is converted to dopamine. People with Parkinson's take L-dopa to control the physical symptoms associated with the lack of dopamine prescribe carbidopa in combination with L-dopa to increase its efficacy within the nervous system, and help combat gastrointestinal symptoms, which are a common side effect of two drugs are usually taken in the form of capsules, containing a combination of the drugs in carefully calculated proportions. To reduce the chance of gastrointestinal symptoms, they should be taken with meals. As fat and protein can decrease the absorption of L-dopa, people must avoid high fat or high protein meals when taking the was the injection developed, and how does it work?The newly developed injection also administers a combination of L-dopa and carbidopa in the form of an in-situ their implant, the researchers used two organic polymers and a solvent, in different ratios to achieve the correct rate of drug release. Once the correct ratio was determined, levodopa and carbidopa were added to create the performed several in-vitro tests to determine the effect of pH (acid/alkali balance), how easy it was to inject the implant, how rapidly the implant degraded and the drugs were dispersed, and the effect of the implant on then tested the mechanism ex vivo in leg muscle tissue from a implant performed similarly in vitro and ex vivo, releasing the drugs slowly over several injection into muscle tissue, pores formed on the surface of the implant, through which the drugs diffused into the tissue. Up to 90% of the drug was released over 7 days, and the implant broke down completely within 2 formula that the researchers developed was easy to inject, so they suggest that this could be a:'Promising drug delivery system for Parkinson's patients, which will reduce the dosing frequency in the elderly patients to once-a-week injection.'Potential problems with long-acting injectionsJamie Adams, MD, associate professor of Neurology at the University of Rochester Medical Center, who was not involved in the study, highlighted potential problems with the treatment:'Given fluctuations in Parkinson's symptoms, it may be difficult to determine appropriate dosing for an entire week, and patients may still require oral medications or other therapies. If the weekly injection is dosed too high, that could also be problematic.'And Mantri also raised some issues that will need to be addressed:'Every medication is different, and this type of gel has not been used for [Parkinson's] treatment before. However, many injectable medications carry the risk of injection site reactions (for instance, rash, nodules) related to the delivery method itself.'Promising early development needs further testingThis is an early stage of development of a new mechanism of drug delivery for people with Parkinson's disease. But it has the potential to transform treatment for elderly people with Parkinson' there are several further stages of testing that would need to be undertaken before the implant could be licensed, as Mantri told Medical News Today:'This is a very preliminary study, looking at how the new treatment behaves in the lab. Further testing on animals and then humans will be necessary as it moves forward in drug development.''I would like to see the results of animal testing, as well as human testing, to ensure that this is both safe and effective,' she agreed:'This treatment is still early, and there needs to be human studies, including randomized controlled trials, evaluating safety and efficacy.''A weekly injectable therapy for Parkinson's disease could reduce the burden of frequent medication dosing and may improve quality of life.'— Jamie Adams


The Guardian
10 hours ago
- The Guardian
Victorian government opposes Moira Deeming-backed push to include ‘transgender ideology' in cults inquiry
Victoria's equality minister says the government will oppose a push to examine 'transgender ideology' as part of an upcoming inquiry into cults. Earlier this month, anti-trans lobby group Binary published a blog post saying the Liberal party MP Moira Deeming was 'urging people to make submissions' to the parliamentary inquiry into cults and organised fringe groups and had 'shared a helpful document with suggested answers'. Deeming has told Guardian Australia she distributed the document that claims transgender ideology 'operates like a cult and harms people in the same way'. The six-page document offers 'tips' for people who believe 'transgender ideology is harmful and cult-like' and stresses submissions highlight three key elements – manipulation, domination and psychological harm. It includes suggested responses for various groups, including parents of transgender children, sports coaches, health professionals and school teachers. One suggested response reads: 'Government enforced Transgender Ideology operates like a cult and harms people in the same way, because we can't leave, we aren't allowed to disagree, we lose our rights against it and it's harmful to us.' The document suggests that submissions call for an investigation into the 'harm caused by the current sex education curriculum', the introduction of 'protections in law for gender-critical beliefs' and 'protections for whistleblowers or conscientious objectors to gender-affirming practices'. It also calls for the 'removal and dismantling of transgender ideology from institutions'. Sign up for Guardian Australia's breaking news email Deeming denied she wrote the document but said she had shared it, as well as another that claimed the government's Covid-19 response – 'including lockdowns, mandates, coercive messaging, censorship and medical segregation' – was 'cult-like'. That document also provides suggested responses to the inquiry and suggests Covid-19 policies 'used coercive control' and health authorities 'behaved like an ideological cult that punished dissent' during the pandemic. 'Neither of the submission tips documents criticise or target any person or community – they both criticise the government,' Deeming told Guardian Australia. Deeming accused the government of 'exploiting minority groups to shield themselves from legitimate criticism'. 'Many people believe the Victorian Labor government's hard line, extreme and oppressive laws used to enforce vaccine mandates and lockdowns, as well as unquestioning submission to the most extreme elements of transgender ideology, meets the threshold for the inquiry's definition of manipulative, coercive and harmful control tactics that cult and fringe groups employ,' Deeming said. But the minister for equality, Vicki Ward, said the inquiry would not cover gender identity or healthcare, as the issues were outside its scope. 'This inquiry has been established to examine harmful and coercive groups, not target trans and gender diverse communities,' Ward said. 'In Victoria, equality is not negotiable. We will continue to fight discrimination and ensure all Victorians can live safely, wholly and freely as their authentic selves.' Sign up to Breaking News Australia Get the most important news as it breaks after newsletter promotion Deeming was expelled from the Liberal party room by the then leader John Pesutto in 2023 after neo-Nazis gatecrashed the Let Women Speak rally she helped organise. After successfully suing Pesutto for defamation last year, she was reinstated and Pesutto was ousted as leader. In April, the new Liberal leader, Brad Battin, appointed Deeming as his 'representative to the western suburbs'. But tensions have emerged between the duo over Battin's involvement in a $1.5m loan to help Pesutto cover Deeming's legal costs. Ward said the document proved the Liberal party remained 'divided' and said Battin faced a 'test of leadership'. Battin's office was approached for comment and asked whether he was aware Deeming was distributing the document and whether it was appropriate to redirect the focus of the inquiry. An opposition spokesperson responded that it was a matter for the inquiry's committee. 'The inquiry should proceed with the terms of reference agreed to by the parliament,' they said. The inquiry was established in April, after allegations of coercive practices at the Geelong Revival Church, as detailed in LiSTNR's investigative podcast series Secrets We Keep: Pray Harder. The church has not publicly commented on the allegations contained in the podcast. Led by the legislative assembly's legal and social issues committee, it begins public hearings on Wednesday, with its first witnesses former members of the church and the podcast's creator, journalist Richard Baker. The committee's chair, Labor MP Ella George, said the inquiry was 'examining techniques being used by certain groups to attract and retain members and whether they amount to coercion that should be criminalised'. She said the inquiry 'does not focus on a group's beliefs or ideology' and pointed to a guidance note on the committee's website for more information. It is understood the committee reviews all submissions to the inquiry, assessing their relevance according to the terms of reference before deciding whether to accept them. Only submissions that are accepted are published online.


Daily Mail
16 hours ago
- Daily Mail
Footy legend's plea as he prepares for monster 200km 'Big Walk' from Penrith to Mudgee: 'matter of time'
NRL great Royce Simmons has admitted it is a matter of time until dementia completely takes over his life, a reality being faced by almost half a million Australians right now. Those estimated 433,000 Australians living with dementia are the reason why the Penrith legend will set out on his fourth annual 'Big Walk' next month, hoping to raise funds for dementia research programs. Simmons, accompanied by fellow ex-players including Terry Lamb and Luke Goodwin, will walk from Penrith for 11 days and more than 200km, beginning on August 13. He'll arrive at Glen Willow Oval in Mudgee for Penrith's round-25 clash against Canberra - a fitting destination for the hero of the Panthers' inaugural grand final win over the Raiders in 1991. But the walk is about much more than footy for Simmons, who was diagnosed with dementia in 2022 at only 61 years of age. I (first) sat around whingeing, really frustrated and cranky with the world,' he said. With an estimated 433,000 Australians living with dementia, the Penrith legend will set out on his fourth annual 'Big Walk' next month from Penrith to Mudgee, hoping to raise funds for research programs 'After I did that for a few months, I thought, get off your bum and get out and try to do something positive. 'That's the reason why I'm in it now, trying to help out as much as I can before the dementia gets me any worse. I know it's only a matter of time until I go down that track.' Even now, as he lies in bed in the morning, it can take Simmons more than half an hour to remember what he did the previous day. 'You wake up in the morning and you think to yourself, 'What did I do yesterday?' You lie there and you think and you think and gradually you work it out,' he said. 'Then I suppose the stage comes where you don't.' Simmons has despaired at seeing his mates go down that path, so he has helped create a 'virtual steps' program that allows donors to pay $30 to complete 30 steps 'alongside him' this year. 'I'm not just crying out to Penrith fans, I'm crying out to all rugby league fans,' he said. Simmons is hopeful he'll arrive in Mudgee for another Penrith win, with the four-time reigning premiers currently on a five-game winning streak that has revived their season. After retiring following Penrith's 1991 premiership, Simmons moved into coaching - including a stint working with the Kangaroos (pictured) under Tim Sheens The 66-year-old said a fifth consecutive NRL premiership shouldn't be out of the question. 'They gradually just build their way into it every year, pick up some momentum, and things are looking positive again this year, but there's still a fair way to go,' he said. Simmons made his NRL debut with the Panthers in 1980, and remained a one-club player, and also turned out for NSW and Australia at representative level. After retiring following Penrith's 1991 premiership, Simmons moved into coaching - and was the assistant at the Wests Tigers under Tim Sheens when they won the 2005 Grand Final as well as with the Kangaroos in 2009.